FDA Warns of Confusion With Brintellix, Brilinta

The FDA July 30 said it is warning health-care professionals and patients that reports of confusion between the antidepressant Brintellix and the anti-blood clotting medication Brilinta have resulted in the wrong medication being prescribed or dispensed.

The Food and Drug Administration said it has determined that the main reason for the confusion between these two medications is the similarity of their branded or proprietary names. None of the reports indicated that a patient ingested the wrong medication; however, reports of prescribing and dispensing errors continue, the agency said.

Brintellix (vortioxetine) is co-marketed by Japan-based Takeda Pharmaceutical Co. and Denmark-based H. ...